Tom Van Blarcom
Company: Kyverna Therapeutics
Job title: Senior Vice President & Head of Research
Seminars:
Developing Allogeneic Cell Therapies for B Cell-Driven Autoimmune Diseases 2:45 pm
Treating autoimmunity with CAR T-cell therapies with demonstrated clinical durability and safety with informed endpoints Guaranteeing therapy safety to comply with regulations for non-fatal disease Educating clinical immunologists about CAR T-cell application to ensure optimal clinical careRead more
day: Day 2 - Track B - PM